PRODUCTS IN DEVELOPMENT
ScanNav Audit currently supports clinicians scanning under the UK Fetal Anomaly Scanning Programme (FASP) protocol. Images taken in a 20 week second trimester scan are assessed when the image is frozen and any issues are highlighted.
ScanNav Audit is particularly useful for newly qualified staff as it gives them confidence when they move into the clinic. More experienced staff have the reassurance that they will not forget to take a required image at the end of a long day. Departments know that every image is saved and available for review, enabling hospitals to provide a 100% audit of the key 20 week anomaly scan.
The system is on trial in St George’s hospital London and the RUH in Bath.
ScanNav will be extended into other protocols following these trials.
ScanNav Autocapture is designed to fully automate the capture of all the key images in the FASP protocol scan, leaving the sonographer free to concentrate on identifying abnormalities within the scan.
During a live scan of the patient, the Autocapture software automatically reviews the ultrasound images being generated by the ultrasound machine and captures any images that meet the agreed protocol criteria
We expect this automation will increase the speed at which a sonographer can scan and access a patient, enabling more patients to be scanned.
We are developing tools for radiologists to reduce the number of cases where abnormalities and pathologies are missed.
ScanNav Assist software tools will work in two ways:
– Checking that the scan does not miss the organ’s borders
– Highlighting any potential areas of abnormality on the ultrasound image
Doctors use interventional needling in a variety of medical procedures including tissue biopsy, cannula insertion and administering regional anaesthesia, in a procedure known as peripheral nerve block (PNB). For many of these procedures, including PNB, the National Institute for Health and Care Excellence (NICE) recommends that ultrasound guidance should always be used.
NeedleGuide aims to combine existing technology developed by MedaPhor, with expertise brought to the Group through the recent acquisition of Intelligent Ultrasound Ltd. The augmented reality headset projects the ultrasound view over the patient’s anatomy, highlighting the pathway the needle needs to follow to the target and then uses artificial intelligence to automatically track the needle tip to ensure that the operator is always aware of the needle’s position in relation to the key anatomical structures. This minimises the potential for user error and offers the opportunity for considerable savings to the hospital.
Products in the pipeline may require US FDA or other regulatory approval, as such this material should be considered informational only and does not constitute an offer to sell or infer claims or benefits.